PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAD3. A total of 7 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $7,840,000,000 | 0.0% | 8,000,000 | 0.0% | 0.07% | -38.1% |
Q1 2021 | $7,840,000,000 | +5.4% | 8,000,000 | 0.0% | 0.11% | -25.7% |
Q4 2020 | $7,440,000,000 | +3.3% | 8,000,000 | 0.0% | 0.15% | -16.9% |
Q3 2020 | $7,200,000,000 | 0.0% | 8,000,000 | 0.0% | 0.18% | +15.1% |
Q2 2020 | $7,200,000,000 | 0.0% | 8,000,000 | 0.0% | 0.16% | +7.4% |
Q1 2020 | $7,200,000,000 | +1.1% | 8,000,000 | 0.0% | 0.15% | -26.4% |
Q4 2019 | $7,120,000,000 | -6.7% | 8,000,000 | 0.0% | 0.20% | -5.2% |
Q3 2019 | $7,628,000,000 | 0.0% | 8,000,000 | 0.0% | 0.21% | +43.2% |
Q2 2019 | $7,628,000,000 | +3.6% | 8,000,000 | 0.0% | 0.15% | -44.2% |
Q4 2018 | $7,360,000,000 | -3.4% | 8,000,000 | 0.0% | 0.26% | +51.4% |
Q3 2018 | $7,620,000,000 | +5.8% | 8,000,000 | 0.0% | 0.18% | +21.5% |
Q2 2018 | $7,200,000,000 | +5.6% | 8,000,000 | +14.3% | 0.14% | +9.9% |
Q1 2018 | $6,816,000,000 | -21.1% | 7,000,000 | -22.2% | 0.13% | -14.4% |
Q4 2017 | $8,638,000,000 | +169.9% | 9,000,000 | +125.0% | 0.15% | +225.5% |
Q3 2017 | $3,200,000,000 | -39.2% | 4,000,000 | -39.2% | 0.05% | -45.3% |
Q2 2017 | $5,263,000,000 | -12.6% | 6,579,000 | -12.6% | 0.09% | -15.7% |
Q1 2017 | $6,020,000,000 | -13.5% | 7,525,000 | -11.7% | 0.10% | -23.9% |
Q4 2016 | $6,956,000,000 | – | 8,525,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,665,000 | $15,276,000 | 0.31% |
ANGELO GORDON & CO., L.P. | 2,879,000 | $2,482,000 | 0.16% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 8,000,000 | $7,200,000,000 | 0.14% |
WOLVERINE ASSET MANAGEMENT LLC | 1,742,000 | $1,509,000 | 0.02% |
CITIGROUP INC | 7,982,000 | $6,883,000 | 0.01% |
Citadel Advisors | 3,700,000 | $3,219,000 | 0.00% |